USD 0.0
(-3.92%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | - USD | 0.0% |
2022 | - USD | 0.0% |
2021 | - USD | 0.0% |
2020 | - USD | -100.0% |
2019 | 16.28 Thousand USD | 0.0% |
2018 | - USD | -100.0% |
2017 | 352.57 Thousand USD | 0.0% |
2015 | 267.59 Thousand USD | 1515.82% |
2014 | 16.56 Thousand USD | 51099.53% |
2013 | 32.35 USD | 0.0% |
2009 | 15.37 Thousand USD | -10.42% |
2008 | 17.16 Thousand USD | -67.85% |
2007 | 53.39 Thousand USD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | - USD | 0.0% |
2024 Q1 | - USD | 0.0% |
2023 Q2 | - USD | 0.0% |
2023 Q1 | - USD | 0.0% |
2023 Q4 | - USD | 0.0% |
2023 FY | - USD | 0.0% |
2023 Q3 | - USD | 0.0% |
2022 FY | - USD | 0.0% |
2022 Q2 | - USD | 0.0% |
2022 Q3 | - USD | 0.0% |
2022 Q4 | - USD | 0.0% |
2022 Q1 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 FY | - USD | 0.0% |
2021 Q2 | - USD | 0.0% |
2020 FY | - USD | -100.0% |
2019 FY | 16.28 Thousand USD | 0.0% |
2018 FY | - USD | -100.0% |
2017 FY | 352.57 Thousand USD | 0.0% |
2015 FY | 267.59 Thousand USD | 1515.82% |
2014 Q2 | 8.30 USD | 0.76% |
2014 FY | 16.56 Thousand USD | 51099.53% |
2014 Q3 | 0.02 USD | -99.76% |
2014 Q1 | 8.24 USD | -11.65% |
2014 Q4 | - USD | -100.0% |
2013 Q3 | 9.79 USD | -6.28% |
2013 FY | 32.35 USD | 0.0% |
2013 Q4 | 9.33 USD | -4.73% |
2013 Q2 | 10.44 USD | 274.47% |
2013 Q1 | 2.79 USD | 0.0% |
2010 Q3 | 1463.00 USD | 7.42% |
2010 Q1 | 2004.00 USD | -29.04% |
2010 Q2 | 1362.00 USD | -32.04% |
2009 FY | 15.37 Thousand USD | -10.42% |
2009 Q4 | 2824.00 USD | -23.47% |
2009 Q1 | 4499.00 USD | 0.0% |
2009 Q3 | 3690.00 USD | -15.48% |
2009 Q2 | 4366.00 USD | -2.96% |
2008 FY | 17.16 Thousand USD | -67.85% |
2007 Q1 | 9098.00 USD | 0.0% |
2007 Q2 | 20.33 Thousand USD | 123.51% |
2007 FY | 53.39 Thousand USD | 0.0% |
2006 Q2 | - USD | 0.0% |
2006 Q1 | - USD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
China Medicine Corporation | 64.75 Million USD | 100.0% |
DH Enchantment Inc. | 686.00 USD | 100.0% |
Exlites Holdings International, Inc. | 18.74 Thousand USD | 100.0% |
Itonis, Inc. | 1801.00 USD | 100.0% |
MediPal Holdings Corporation | 23.51 Billion USD | 100.0% |
PD-Rx Pharmaceuticals, Inc. | 21.27 Million USD | 100.0% |
Pharmagen, Inc. | 4813.05 USD | 100.0% |
Suzuken Co., Ltd. | 15.76 Billion USD | 100.0% |